| 000 | 01671 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515113516.0 | ||
| 264 | 0 | _c20080904 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/j.ejca.2008.02.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNorum, Jan | |
| 245 | 0 | 0 |
_aProphylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cMay 2008 |
||
| 300 |
_a963-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Distribution |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBreast Neoplasms _xeconomics |
| 650 | 0 | 4 | _aCost Savings |
| 650 | 0 | 4 | _aCost of Illness |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, BRCA1 |
| 650 | 0 | 4 |
_aGerm-Line Mutation _xgenetics |
| 650 | 0 | 4 | _aHealth Care Costs |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMarkov Chains |
| 650 | 0 | 4 |
_aMastectomy _xeconomics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorway _xepidemiology |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xeconomics |
| 650 | 0 | 4 |
_aOvariectomy _xeconomics |
| 700 | 1 | _aHagen, Anne Irene | |
| 700 | 1 | _aMaehle, Lovise | |
| 700 | 1 | _aApold, Jaran | |
| 700 | 1 | _aBurn, John | |
| 700 | 1 | _aMøller, Pål | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 44 _gno. 7 _gp. 963-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2008.02.025 _zAvailable from publisher's website |
| 999 |
_c17862681 _d17862681 |
||